AdaptHealth
AHCO
13 hedge funds and large institutions have $73.5M invested in AdaptHealth in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
24.41% more ownership
Funds ownership: 0% → 24.41% (+24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$19.4M |
| 2 |
LA
Linden Advisors
New York
|
+$11.9M |
| 3 |
MCM
Moore Capital Management
New York
|
+$9.71M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.28M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$7.28M |
Top Sellers
AHCO Hedge Fund Activity: Q2 2018 in Review
13 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2018, worth a combined $73.5M.
Buyers outnumbered sellers: 13 funds opened new AHCO positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $19.4M.
- 13 institutional investors held AdaptHealth (AHCO) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $73.5M of AdaptHealth stock for Q2 2018.
- 13 funds opened new AdaptHealth positions in Q2 2018 and 0 closed out, a net change of +13 holders.
- The largest AdaptHealth buyer in Q2 2018 was AQR Arbitrage, an estimated $19.4M added.
Based on aggregated 13F filings for Q2 2018.